Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| MEDGENICS, INC. | 175,746 | reported | 09 Jun 2020 | tx 25+6,359,454−5,759,454 |
| SAFEGUARD SCIENTIFICS INC | 100,000 | reported | 12 Jan 2004 | tx 1+100,000 |
| Avalo Therapeutics, Inc. | 78,116 | reported | 01 Oct 2021 | tx 11+2,716,960 |
| Phathom Pharmaceuticals, Inc. | 63,920 | reported | 19 May 2026 | tx 11+133,920−17,500 |
| CLARIENT, INC | 30,000 | reported | 11 Apr 2006 | tx 1+30,000 |
| Vanda Pharmaceuticals Inc. | 15,000 | reported | 13 Jun 2019 | tx 11+140,000 |
| NUPATHE INC. | 0 | reported | 21 Feb 2014 | tx 40+111,767−152,314 |
| Sage Therapeutics, Inc. | 0 | reported | 31 Jul 2025 | tx 13+156,674−21,500 |
2 purchases reported after at least 12 months of silence — most recent on 29 Oct 2019.
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 19 May 2026 | GRANT_AWARD | Phathom Pharmaceuticals, Inc. | 24,122 | 0.00 USD | |
| 31 Jul 2025 | OTHER | Sage Therapeutics, Inc. | 21,500 | — | deriv |
| 11 Jun 2025 | GRANT_AWARD | Sage Therapeutics, Inc. | 21,500 | 0.00 USD | deriv |
| 03 Jun 2025 | GRANT_AWARD | Phathom Pharmaceuticals, Inc. | 10,500 | 0.00 USD | |
| 03 Jun 2025 | GRANT_AWARD | Phathom Pharmaceuticals, Inc. | 17,500 | 0.00 USD | deriv |
| 10 Jun 2024 | GRANT_AWARD | Sage Therapeutics, Inc. | 12,500 | 0.00 USD | deriv |
| 23 May 2024 | GRANT_AWARD | Phathom Pharmaceuticals, Inc. | 10,500 | 0.00 USD | |
| 23 May 2024 | GRANT_AWARD | Phathom Pharmaceuticals, Inc. | 17,500 | 0.00 USD | deriv |
| 15 Jun 2023 | GRANT_AWARD | Sage Therapeutics, Inc. | 10,000 | 0.00 USD | deriv |
| 25 May 2023 | GRANT_AWARD | Phathom Pharmaceuticals, Inc. | 9,000 | 0.00 USD | |
| 25 May 2023 | GRANT_AWARD | Phathom Pharmaceuticals, Inc. | 15,000 | 0.00 USD | deriv |
| 16 Jun 2022 | GRANT_AWARD | Sage Therapeutics, Inc. | 9,947 | 0.00 USD | deriv |
| 25 May 2022 | GRANT_AWARD | Phathom Pharmaceuticals, Inc. | 15,000 | 0.00 USD | deriv |
| 29 Oct 2019 | PURCHASE | Phathom Pharmaceuticals, Inc. | 9,798 | 19.00 USD | first after silence |
| 01 Oct 2021 | GRANT_AWARD | Avalo Therapeutics, Inc. | 78,116 | 0.00 USD | deriv |
| 01 Jul 2021 | GRANT_AWARD | Avalo Therapeutics, Inc. | 51,740 | 0.00 USD | deriv |
| 10 Jun 2021 | GRANT_AWARD | Sage Therapeutics, Inc. | 10,000 | 0.00 USD | deriv |
| 21 May 2021 | GRANT_AWARD | Phathom Pharmaceuticals, Inc. | 12,500 | 0.00 USD | deriv |
| 01 Apr 2021 | GRANT_AWARD | Avalo Therapeutics, Inc. | 70,881 | 0.00 USD | deriv |
| 26 Jan 2021 | GRANT_AWARD | Avalo Therapeutics, Inc. | 850,000 | 0.00 USD | deriv |
| 04 Jan 2021 | GRANT_AWARD | Avalo Therapeutics, Inc. | 64,798 | 0.00 USD | deriv |
| 01 Oct 2020 | GRANT_AWARD | Avalo Therapeutics, Inc. | 76,674 | 0.00 USD | deriv |
| 01 Jul 2020 | GRANT_AWARD | Avalo Therapeutics, Inc. | 64,683 | 0.00 USD | deriv |
| 18 Jun 2020 | GRANT_AWARD | Avalo Therapeutics, Inc. | 84,322 | 0.00 USD | deriv |
| 09 Jun 2020 | GRANT_AWARD | Sage Therapeutics, Inc. | 10,000 | 0.00 USD | deriv |